Compare ENVA & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENVA | NOVT |
|---|---|---|
| Founded | 2011 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.0B |
| IPO Year | 2011 | 1999 |
| Metric | ENVA | NOVT |
|---|---|---|
| Price | $252.99 | $168.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $185.71 | $144.00 |
| AVG Volume (30 Days) | 331.7K | ★ 444.8K |
| Earning Date | 04-23-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.05 | N/A |
| EPS | ★ 7.45 | 0.82 |
| Revenue | ★ $3,151,653,000.00 | $521,290,000.00 |
| Revenue This Year | $149.64 | $8.61 |
| Revenue Next Year | $16.42 | $6.57 |
| P/E Ratio | ★ $34.36 | $199.17 |
| Revenue Growth | 18.58 | ★ 35.49 |
| 52 Week Low | $103.02 | $98.27 |
| 52 Week High | $265.54 | $176.38 |
| Indicator | ENVA | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 63.53 | 62.25 |
| Support Level | $217.38 | $146.45 |
| Resistance Level | N/A | $167.79 |
| Average True Range (ATR) | 8.71 | 6.87 |
| MACD | 0.68 | 2.29 |
| Stochastic Oscillator | 81.18 | 67.75 |
Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.